Israel · Delayed Price · Currency is ILS · Price in ILA Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 570.15 million. The enterprise value is 400.81 million.
| Market Cap | 570.15M |
| Enterprise Value | 400.81M |
Important Dates
The next estimated earnings date is Wednesday, November 25, 2026.
| Earnings Date | Nov 25, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
Ilex Medical has 11.19 million shares outstanding. The number of shares has decreased by -0.30% in one year.
| Current Share Class | 11.19M |
| Shares Outstanding | 11.19M |
| Shares Change (YoY) | -0.30% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 62.77% |
| Owned by Institutions (%) | 12.82% |
| Float | 2.84M |
Valuation Ratios
The trailing PE ratio is 14.65.
| PE Ratio | 14.65 |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | 11.71 |
| P/OCF Ratio | 6.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.26, with an EV/FCF ratio of 8.23.
| EV / Earnings | 10.30 |
| EV / Sales | 0.45 |
| EV / EBITDA | 5.26 |
| EV / EBIT | 13.68 |
| EV / FCF | 8.23 |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.07 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.55 |
| Debt / FCF | 1.01 |
| Interest Coverage | 19.86 |
Financial Efficiency
Return on equity (ROE) is 5.85% and return on invested capital (ROIC) is 6.03%.
| Return on Equity (ROE) | 5.85% |
| Return on Assets (ROA) | 2.81% |
| Return on Invested Capital (ROIC) | 6.03% |
| Return on Capital Employed (ROCE) | 5.70% |
| Weighted Average Cost of Capital (WACC) | 3.15% |
| Revenue Per Employee | 4.89M |
| Profits Per Employee | 214,934 |
| Employee Count | 181 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 4.06 |
Taxes
In the past 12 months, Ilex Medical has paid 14.57 million in taxes.
| Income Tax | 14.57M |
| Effective Tax Rate | 27.25% |
Stock Price Statistics
The stock price has decreased by -15.55% in the last 52 weeks. The beta is -0.20, so Ilex Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -15.55% |
| 50-Day Moving Average | 4,990.62 |
| 200-Day Moving Average | 5,707.84 |
| Relative Strength Index (RSI) | 54.58 |
| Average Volume (20 Days) | 972 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 885.35 million and earned 38.90 million in profits. Earnings per share was 3.48.
| Revenue | 885.35M |
| Gross Profit | 197.57M |
| Operating Income | 42.76M |
| Pretax Income | 53.47M |
| Net Income | 38.90M |
| EBITDA | 75.47M |
| EBIT | 42.76M |
| Earnings Per Share (EPS) | 3.48 |
Balance Sheet
The company has 218.38 million in cash and 49.04 million in debt, with a net cash position of 169.34 million or 15.14 per share.
| Cash & Cash Equivalents | 218.38M |
| Total Debt | 49.04M |
| Net Cash | 169.34M |
| Net Cash Per Share | 15.14 |
| Equity (Book Value) | 670.18M |
| Book Value Per Share | 60.05 |
| Working Capital | 425.35M |
Cash Flow
In the last 12 months, operating cash flow was 85.86 million and capital expenditures -37.16 million, giving a free cash flow of 48.70 million.
| Operating Cash Flow | 85.86M |
| Capital Expenditures | -37.16M |
| Depreciation & Amortization | 32.70M |
| Net Borrowing | -14.58M |
| Free Cash Flow | 48.70M |
| FCF Per Share | 4.35 |
Margins
Gross margin is 22.32%, with operating and profit margins of 4.83% and 4.39%.
| Gross Margin | 22.32% |
| Operating Margin | 4.83% |
| Pretax Margin | 6.04% |
| Profit Margin | 4.39% |
| EBITDA Margin | 8.52% |
| EBIT Margin | 4.83% |
| FCF Margin | 5.50% |
Dividends & Yields
This stock pays an annual dividend of 1.99, which amounts to a dividend yield of 3.75%.
| Dividend Per Share | 1.99 |
| Dividend Yield | 3.75% |
| Dividend Growth (YoY) | 62.87% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 57.12% |
| Buyback Yield | 0.30% |
| Shareholder Yield | 4.05% |
| Earnings Yield | 6.82% |
| FCF Yield | 8.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
| Last Split Date | Aug 21, 2000 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
Ilex Medical has an Altman Z-Score of 3.9 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.9 |
| Piotroski F-Score | 4 |